Abstract Search

ea0029p1448 | Pituitary Clinical | ICEECE2012

National incidence and prevalence of TSH-secreting pituitary adenomas in Sweden

Onnestam L. , Berinder K. , Bramnert M. , Burman P. , Dahlqvist P. , Eden-Engstrom B. , Wahlberg Topp J. , Filipsson Nystrom H.

Introduction: TSH-secreting pituitary adenomas (TSHoma) are rare. Epidemiological data are scant and there are no reports on national incidence. The aim of this study was to estimate the national incidence and prevalence of TSHomas in Sweden.Methods: This is an observational study from all tertial referral centers where the Swedish Pituitary Registry and WHO ICD coding were used to identify patients diagnosed with TSHomas in Sweden 19902010. Medica...

0 shares

ea0029p78 | Adrenal cortex | ICEECE2012

An open, multi-centre, phase IIIB, long term follow-up study to assess the safety, tolerability and efficacy of once-daily oral dual-release hydrocortisone in patients with adrenal insufficiency

Johannsson G. , Nilsson A. , Bergthorsdottir R. , Burman P. , Dahlqvist P. , Ekman B. , Eden Engstrom B. , Ragnarsson O. , Ryberg M. , Wahlberg J. , Skrtic S.

Introduction: There are limited prospective safety data on glucocorticoid replacement. The aim of this study was to assess the safety and efficacy during long term treatment using a once-daily oral dual-release hydrocortisone in patients with adrenal insufficiency (AI).Methods: This is an open, multi-centre study in 71 patients with AI. Most patients were recruited from a previous controlled trial (n=53) where they had received the dual-release th...

1 shares

Endocrine Abstracts

National incidence and prevalence of TSH-secreting pituitary adenomas in Sweden

An open, multi-centre, phase IIIB, long term follow-up study to assess the safety, tolerability and efficacy of once-daily oral dual-release hydrocortisone in patients with adrenal insufficiency

BiosciAbstracts